About Airway Therapeutics
Airway Therapeutics is a private company based in Marietta, Georgia. It has reported $54,427,249 raised in two offerings on Form D since March 2018. Its chief executive is Marc Salzberg.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Sep 9, 2026 | $43,496,282of $50.5M target | 116 | $374K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 1, 2018 | Mar 13, 2018 | $10,930,967of $11.0M target | 39 | $280K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $54,427,249 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Airway Therapeutics's Form D filed Sep 9, 2026.
Earlier filings also listed Michael Venerable (director, last listed Mar 2018), John Rice (director, last listed Mar 2018) and Jennifer Dauer (director, last listed Mar 2018).
Sources
- SECAirway Therapeutics, Inc. filing history
- CompanyCompany overview
- CompanyLeadership